Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.

Myasthenia gravis (MG) and experimental autoimmune myasthenia gravis (EAMG) are caused, in part, by the production of autoantibodies against the main immunogenic region, amino acids 61-76, of the alpha chain of the acetylcholine receptor (AChR). Theoretically, induction of anti-idiotypic (Id) antibo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Araga, S, LeBoeuf, R D, Blalock, J E
Natura: Artigo
Lingua:Inglês
Pubblicazione: 1993
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC47435/
https://ncbi.nlm.nih.gov/pubmed/8378359
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi